The contributions of inflammatory cocktail and stromal cell origin on a scaffold-free 3D biofabricated SSuPer tissue of endometriosis and normal endometrium

炎症混合物和基质细胞起源对子宫内膜异位症和正常子宫内膜无支架 3D 生物制造 SSuPer 组织的贡献

基本信息

项目摘要

Endometriosis is a debilitating disease that affects up to 10% of U.S. women. While treatments exist, more than 50% of women with endometriosis will have disease recurrence. The lack of useful models continues to impede the discovery of aspects of pathophysiology that are amenable to novel interventions. Therefore, there is an urgent need to develop novel models of endometriosis to advance the field significantly. This application proposes to create 3D biofabricated SSuPer (Self-Supporting Perfused) tissues that recapitulate either endometriosis or normal endometrium using the Kenzan method. The Kenzan method uses the Regenova Bio 3D Printer to place multicellular spheroids onto a microneedle array, called a Kenzan. On Kenzan, the spheroids fuse through cell-cell interaction and secretion of their native extracellular matrix, allowing more intrinsic intercellular communication. Intercellular communication between epithelial and stromal cells is paramount in endometrial function. Preliminary data shows that the Kenzan method effectively biofabricates the first scaffold-free 3D bioprinted constructs comprised of both endometriotic epithelial and endometrial stromal cells. Further, SSuPer tissues contain microchannels that can be perfused in a biologically inert FABRICA bioreactor. Because human endometrial stromal fibroblasts are critical to uterine function, stromal fibroblasts from women with endometriosis can be used to model the abnormal cellular function, aberrant molecular signaling, and pro-inflammatory transcriptomic profiles that occur in endometriosis. Additionally, pro- inflammatory mediators are elevated in the peritoneal fluid of women with endometriosis and likely play a role in progesterone resistance. This application's objective is to biofabricate 3D models of both endometriosis and normal endometrium, which recapitulate the inflammatory, transcriptomic, and steroid hormone response faithfully. The central hypothesis is that both inflammatory cytokines and stromal cell origin (i.e., endometriosis or not) independently affect the endometriotic or endometrial phenotype of each SSuPer tissue. SSuPer tissues, comprised of epithelial and stromal cells from either endometriosis or normal endometrium, will be biofabricated and perfused with either media or media with an inflammatory cocktail. SSuPer tissues will be determined to be either endometriosis or normal endometrium by inflammatory marker secretion, expression of endometriosis biomarkers, and global transcriptomic changes. Secondary validation studies will focus on steroid hormone response. The research proposed in this application is innovative because it will generate novel scaffold-free 3D biofabricated SSuPer tissues that maintain high biological fidelity to endometriosis or normal endometrium. Rigorously validated in vitro models will provide useful models for investigating the pathophysiology of endometriosis and other uterine dysfunction diseases such as infertility and recurrent pregnancy loss. Highly reproducible models are necessary for testing novel therapies.
子宫内膜异位症是一种使人衰弱的疾病,可影响多达10%的美国妇女。虽然存在治疗,但不仅仅是 子宫内膜异位症的女性中有50%会复发。缺乏有用的模型继续阻碍 发现新干预措施的病理生理学方面。因此,有一个 迫切需要开发新型子宫内膜异位症模型,以显着推进该领域。此应用程序 提议创建3D生物制造的ssuper(自支持的灌注)组织 使用Kenzan方法的子宫内膜异位症或正常子宫内膜。 Kenzan方法使用Regenova Bio 3D打印机将多细胞球体放置在称为kenzan的微针阵列上。在肯赞,球体 通过细胞细胞相互作用和分泌其天然细胞外基质的融合,允许更多固有 细胞间沟通。上皮和基质细胞之间的细胞间通信至关重要 子宫内膜功能。初步数据表明,肯赞方法有效地生物制作了第一个 不含脚手架的3D生物打印构建体,包括子宫内膜上皮和子宫内膜 基质细胞。此外,ssuper组织含有微通道,可以在生物学上渗透 Fabrica生物反应器。因为人子宫内膜基质成纤维细胞对子宫功能至关重要 子宫内膜异位女性的成纤维细胞可用于模拟异常细胞功能,异常 子宫内膜异位症中发生的分子信号传导和促炎的转录谱。另外,亲 子宫内膜异位症女性的腹膜液中炎症介质的升高,并可能在 孕酮耐药性。该应用的目的是生物制造的3D子宫内膜异位症和 正常子宫内膜,概括炎症,转录组和类固醇激素反应 忠实。中心假设是炎性细胞因子和基质细胞起源(即子宫内膜异位症) 是否)独立影响每个ssuper组织的子宫内膜或子宫内膜表型。 ssuper组织, 由子宫内膜异位症或正常子宫内膜的上皮细胞和基质细胞组成,将被生物制作 并用炎症鸡尾酒灌注媒体或媒体。 ssuper组织将被确定为 子宫内膜异位症或正常子宫内膜通过炎症标记分泌,子宫内膜异位表达 生物标志物和全球转录组变化。二级验证研究将集中于类固醇激素 回复。本应用程序中提出的研究具有创新性,因为它将产生新颖的脚手架3D 生物生物制造的ssuper组织,可维持对子宫内膜异位症或正常子宫内膜的高生物保真度。 经过严格验证的体外模型将提供有用的模型来研究 子宫内膜异位症和其他子宫功能障碍疾病,例如不育症和复发性妊娠丧失。高度 可再现模型对于测试新疗法是必需的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shannon Michelle Hawkins其他文献

Shannon Michelle Hawkins的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shannon Michelle Hawkins', 18)}}的其他基金

Targeting cellular senescence to inhibit the development and progression of ovarian endometriomas
靶向细胞衰老抑制卵巢子宫内膜异位症的发生和进展
  • 批准号:
    10512390
  • 财政年份:
    2022
  • 资助金额:
    $ 23.78万
  • 项目类别:
Targeting cellular senescence to inhibit the development and progression of ovarian endometriomas
靶向细胞衰老抑制卵巢子宫内膜异位症的发生和进展
  • 批准号:
    10698079
  • 财政年份:
    2022
  • 资助金额:
    $ 23.78万
  • 项目类别:
The contributions of inflammatory cocktail and stromal cell origin on a scaffold-free 3D biofabricated SSuPer tissue of endometriosis and normal endometrium
炎症混合物和基质细胞起源对子宫内膜异位症和正常子宫内膜无支架 3D 生物制造 SSuPer 组织的贡献
  • 批准号:
    10380176
  • 财政年份:
    2021
  • 资助金额:
    $ 23.78万
  • 项目类别:

相似国自然基金

面向3D打印平行机的精确调度算法与动态调整机制研究
  • 批准号:
    72301196
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
适于3D打印的肌球蛋白微凝胶Pickering乳液富脂鱼糜的稳定机制
  • 批准号:
    32360595
  • 批准年份:
    2023
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
基于3D生物打印类器官模型探究PAK5调控三阴性乳腺癌铂类耐药的机制研究
  • 批准号:
    82303979
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
构建生物3D打印类器官芯片模型研究弹性蛋白-整合素在胃癌免疫微环境中的作用
  • 批准号:
    32371472
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
3D打印功能化仿生神经纤维修复脊髓损伤的作用及机制研究
  • 批准号:
    82301560
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Multi-tissue type condensations for trachea tissue regeneration via individual cell bioprinting
通过单细胞生物打印进行气管组织再生的多组织类型浓缩
  • 批准号:
    10643041
  • 财政年份:
    2023
  • 资助金额:
    $ 23.78万
  • 项目类别:
Individual cell bioprinting to generate multi-tissue type condensations for osteochondral tissue regeneration
单个细胞生物打印可生成用于骨软骨组织再生的多组织类型浓缩物
  • 批准号:
    10659772
  • 财政年份:
    2023
  • 资助金额:
    $ 23.78万
  • 项目类别:
Modality-independent representations of object shape in macaque inferotemporal cortex
猕猴下颞叶皮层物体形状的模态无关表示
  • 批准号:
    10679530
  • 财政年份:
    2023
  • 资助金额:
    $ 23.78万
  • 项目类别:
Modernization of 3-dimensional printing capabilities at the Aquatic Germplasm and Genetic Resource Center
水产种质和遗传资源中心 3 维打印能力的现代化
  • 批准号:
    10736961
  • 财政年份:
    2023
  • 资助金额:
    $ 23.78万
  • 项目类别:
A novel breast cancer therapy based on secreted protein ligands from CD36+ fibroblasts
基于 CD36 成纤维细胞分泌蛋白配体的新型乳腺癌疗法
  • 批准号:
    10635290
  • 财政年份:
    2023
  • 资助金额:
    $ 23.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了